Psyence Biomedical Ltd. (PBM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Psyence Biomedical Ltd.

    NASDAQ: PBM · Real-Time Price · USD
    2.69
    0.11 (4.26%)
    At close: Sep 05, 2025, 3:59 PM
    2.69
    0.00%
    After-hours: Sep 05, 2025, 07:49 PM EDT

    Psyence Biomedical Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 240.00 n/a n/a
    Gross Profit
    		 -240 n/a n/a
    Operating Income
    		 -2.75M -1.29M -334.29K
    Interest Income
    		 2.13K 1.55K n/a
    Pretax Income
    		 -51.16M 8.01M 8.23M
    Net Income
    		 -51.16M 8.01M 8.23M
    Selling & General & Admin
    		 1.8M 1.63M 1.72M
    Research & Development
    		 954.59K 1.61M 137.24K
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 2.75M 1.29M 334.29K
    Interest Expense
    		 52.94K n/a n/a
    Selling & Marketing Expenses
    		 80.6K 7.03K 17.51K
    Cost & Expenses
    		 2.75M 1.29M 334.29K
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 6.52M 32.67M 32.67M
    Shares Outstanding (Diluted)
    		 6.52M 32.67M 32.67M
    EPS (Basic)
    		 -7.85 -0.64 0.25
    EPS (Diluted)
    		 -7.85 -0.64 0.25
    EBITDA
    		 -2.75M -1.29M -334.29K
    EBIT
    		 -51.11M n/a n/a
    Depreciation & Amortization
    		 240.00 n/a n/a

    Add to Watchlist